Loss of negative regulators amplifies RAS signaling

Related Experiment Video

Updated: Apr 14, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

Rebecca Lock1, Karen Cichowski1

  • 1Genetics Division at the Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Nature Genetics
|April 29, 2015
PubMed

Insights

SPRY4 functions as a tumor suppressor in acute myeloid leukemia. Its loss promotes RAS signaling, suggesting a new mechanism in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
  • RAS signaling pathways are frequently dysregulated in various cancers, including AML.
  • Tumor suppressors play a critical role in preventing uncontrolled cell proliferation.

Purpose of the Study:

  • To investigate the role of SPRY4 in acute myeloid leukemia.
  • To elucidate the mechanism by which SPRY4 loss affects RAS signaling.
  • To explore potential cooperative interactions among negative regulators of the RAS pathway.

Main Methods:

  • Gene expression analysis in AML patient samples.
  • Functional assays to assess the impact of SPRY4 on cell proliferation and signaling.
  • Western blotting to detect protein levels and pathway activation.

Main Results:

  • SPRY4 is identified as a novel tumor suppressor in acute myeloid leukemia.
  • Loss of SPRY4 expression leads to enhanced RAS signaling.
  • A cooperative mechanism is proposed where combined loss of RAS pathway inhibitors can drive oncogenesis without requiring canonical RAS mutations.

Conclusions:

  • SPRY4 is a critical negative regulator of RAS signaling in AML.
  • Loss of SPRY4 represents an alternative route to RAS pathway activation in AML.
  • Targeting negative regulators of the RAS pathway may offer therapeutic strategies for AML.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
Inducible and Reversible Dominant-negative DN Protein Inhibition08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.8K
The Ras Gene02:38

The Ras Gene

2.6K